0.00Open0.00Pre Close0 Volume0 Open Interest12.50Strike Price0.00Turnover195.41%IV-80.64%PremiumNov 15, 2024Expiry Date5.58Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9641Delta0.0410Gamma1.24Leverage Ratio-0.0076Theta-0.0017Rho-1.19Eff Leverage0.0008Vega
Cognyte Software Stock Discussion
Cognyte Customer in EMEA Safeguards National Interests with $20-plus Million Agreement
Value Base’s proposals receive support of Neuberger Berman, a leading global investment manager and a top shareholder of Cognyte, which intends to vote at the Cognyte Software AGM:
Value Base, Cognyte Software's largest shareholder (9.33% stake), announces support from Neuberger Berman (7.16% stake) for its proposals at the upcoming AGM. Both major shareholders advocate for:
Voting AGAINST Chairman Earl Shanks' re-election
Voting AGAINST the CEO compensation plan
...
Cognyte Secures $10 Million Expansion with National Security Agency in EMEA
Cognyte Software (NASDAQ: CGNT) announced a $10 million follow-on order from a national security agency in the EMEA region. This long-term client will utilize Cognyte's advanced investigative analytics to derive more insights from increasing data volumes, combatting threats like terrorism, drug trafficking, and weapons smuggling. The order highlights the customer's satisfaction with Cognyt...
NEWS
Cognyte to Participate in the TD Cowen 52nd Annual Technology, Media & Telecom Conference
Cognyte Software (NASDAQ: CGNT) announced that its CEO, Elad Sharon, and CFO, David Abadi, will participate in an in-person fireside chat at the TD Cowen 52nd Annual Technology, Media & Telecom Conference.
The event will occur on Wednesday, May 29, 2024, at 10:15am ET. An online, real-time webcast and replay of the discussion will be available on Cognyte's investor relations...
$Pfizer (PFE.US)$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ...
$Target (TGT.US)$ +1.14% (Target announced it would increase its dividend by 1.9%, or 2 cents, to $1.10 per share.)
$Aldeyra Therapeutics (ALDX.US)$ +7.89% (Aldeyra announced it say statistical significance in the primary and all secondary endpoints for a drug that could be used for a type of eye inflammation.)
$Domino's Pizza (DPZ.US)$ +2.31% (The pizza chain rose 2.3% following an upgrade to buy from hold by Stifel. The firm ...
In company news, Cognyte Software $Cognyte Software (CGNT.US)$ rose almost 14% after the investigative analytics software firm Wednesday reported a non-GAAP loss of $0.04 per share in Q2, reversing a $0.17 per share adjusted p...
No comment yet